Diebold Nixdorf, Incorporated research snapshot
DBD AI stock analysis currently reads Diebold Nixdorf as a restructured ATM and retail technology leader with improving margins, a cleaner balance sheet, and a dominant installed base across 130 countries, but with post-Chapter 11 equity dilution, debt leverage, modest near-term EPS, and a stock that already reflects much of the turnaround. At the July 12, 2026 data cutoff, DBD traded near $85.26 with a verified market capitalization near $2.95 billion. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$85.26
Market cap
$2.95 billion
AI score
67 / 100
Rating
Post-bankruptcy ATM leader, recovery priced in
Trend status
Trending up from 52-week low with strong YTD performance but near resistance
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Diebold Nixdorf is the largest ATM manufacturer in the US with a global installed base, service network, and retail POS systems, but the business carries moderate capital intensity, hardware cyclicality, and post-bankruptcy financial scars. | Medium |
| Moat | Moat comes from the global installed base of ATMs and retail POS terminals, service contracts, software integration (DN Vynamic), and long-term bank relationships, but switching costs for hardware are lower than for software platforms. | Medium-low |
| Management | CEO Octavio Marquez led the company through Chapter 11 restructuring, debt reduction, and relisting with a focus on banking and retail technology. Capital allocation discipline and the ability to sustain post-restructuring growth are still unproven over a full cycle. | Medium |
| Financial trend | Revenue has stabilized around $3.75-$3.86B post-bankruptcy with modest profitability in recent quarters, but Q1 FY26 net income dropped to $5.0M and the full FY2024 net loss of -$15M shows the turnaround is still early. | Medium |
| Valuation | At $85.26, DBD trades near 29x trailing EPS, 0.79x sales, 2.82x book, and 9.1x FCF. The P/E appears high for the earnings level but EV/EBITDA near 9.6x and P/FCF near 9.1x are more reasonable for a post-restructuring industrial technology company. | Medium |
| Technical trend | The stock has rallied strongly from the 52-week low of $53.93 and sits near the 52-week high of $89.05. Near-term resistance around $87-$89 needs to clear for further upside. Momentum is positive but approaching overbought territory. | Medium |
| Risk level | Key risks include debt leverage (D/E ~107%), modest post-bankruptcy profitability, ATM market maturity, competition from NCR and Hyosung, pressure on bank branch spending, and a limited analyst coverage base that reduces price discovery. | Medium |
| AI confidence | High for descriptive facts and verified calculations, medium for forward scenarios and chart levels given the thin post-restructuring trading history. | High data confidence |
| Investment certainty | Low-medium certainty. The page frames scenarios and monitoring rules, not a buy or sell instruction. The turnaround is progressing but much of the upside may already be discounted at the current price. | Low-medium |
DBD AI stock forecast
The DBD AI stock forecast uses scenario math around the $85.26 quote and current EPS of $2.94. The verified three-year framework produced a bearish area near $32, a base area near $59, and a bullish area near $98. The wide range reflects the uncertainty around post-bankruptcy earnings trajectory and appropriate valuation multiples.
$95 to $105
More likely if Diebold Nixdorf sustains mid-teens EPS growth through service revenue expansion, banking software upselling, margin improvement from restructuring benefits, and the market assigns a premium multiple near 22x earnings as confidence in the turnaround firms.
$55 to $65
More likely if EPS growth runs around mid-single digits, revenue stays near $3.8-$4.0B, operating margins improve slowly, and the stock trades near 16x earnings, which is reasonable for a post-restructuring industrial technology company with moderate growth.
$28 to $36
More likely if growth stalls, ATM replacement cycles slow, debt servicing costs constrain margins, or the market prices the stock closer to 11x earnings due to limited visibility and competitive pressure from NCR Atleos and regional ATM providers.
DBD AI technical analysis
DBD AI technical analysis shows a strong uptrend from the 52-week low but with the stock approaching a key resistance zone near $87-$89 as of the July 12, 2026 data cutoff. The stock has more than doubled from the bankruptcy-era lows but the RSI may be approaching overbought territory, suggesting a consolidation or pullback risk near current levels.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $85.26 | Quote snapshots around the July 10, 2026 close placed DBD near $85.26 with a market cap just under $3B. |
| Near support | $80 to $83 | The 20-day moving average and recent consolidation zone near $80-$83 provide the first support area if the stock pulls back from resistance. |
| Deeper support | $72 to $75 | The 50-day moving average and prior breakout level near $72-$75 represent a deeper support zone if the near-term uptrend stalls. |
| Near resistance | $87 to $89 | The 52-week high near $89.05 and recent highs around $87-$89 form a clear resistance zone. A decisive break above this level would be a positive technical signal. |
| Long-term resistance | $100 | The analyst consensus price target sits at $100, making this a psychological and fundamental resistance level if the stock clears the 52-week high. |
| Momentum | RSI trending toward 60-65 | Momentum is positive after the strong YTD rally, but the RSI is approaching levels that historically preceded consolidation or pullbacks. |
| Volume | Average volume near 320K shares | Average volume is relatively low at 320K shares, which can amplify price moves and make breakouts or breakdowns less reliable. |
| Volatility | About 58% above the 52-week low | The stock has recovered significantly from the $53.93 low but still has room to the $89.05 high, creating a wide trading range. |
| Invalidation | Close below $75 | A decisive close below the 50-day moving average area near $75 would suggest the uptrend has stalled and a deeper correction may be underway. |
DBD AI trading strategy
The DBD AI trading strategy is a rules-based research framework for monitoring a post-restructuring ATM and retail technology stock with positive momentum but limited liquidity. It is not personal advice and should be paired with fresh chart data, earnings reports, position sizing, and a defined invalidation level.
Watch for DBD to clear the $87-$89 resistance zone on above-average volume, ideally after a Q2 FY26 earnings beat or raised guidance. A sustained move toward the $95-$100 area would confirm the post-restructuring trend is intact.
A close below $80 or a failed breakout above the 52-week high should invalidate the near-term trend-following setup. The low average volume means position sizing should account for wider spreads.
If DBD pulls back toward the $80-$83 zone without a negative earnings revision, compare the pullback with service revenue growth, operating margin trends, and debt reduction progress before assuming support is durable.
Do not average down without a maximum loss rule because post-bankruptcy stocks can gap on earnings misses, dilution news, or competitive developments.
Track quarterly revenue and EPS trajectory, service and software revenue share, operating margin improvement, debt reduction, free cash flow generation, and banking sector capex trends.
Reduce confidence if revenue growth depends mainly on pricing or one-time items instead of organic service and software expansion, or if net leverage does not improve over the next two quarters.
Investment research summary
Diebold Nixdorf provides ATMs, cash recyclers, POS systems, and banking software to financial institutions and retailers across 130 countries. Customers pay because the hardware, service, and software integration keeps their self-service channels running.
The moat is moderate and based on installed base scale, global service network, banking software integration (DN Vynamic), and long-term contracts with financial institutions, but hardware competition from NCR Atleos, Hyosung, and regional players limits pricing power.
The thesis fails if debt restructuring benefits prove temporary, EPS growth stalls below expectations, ATM market growth slows as digital banking reduces cash usage, or competitive pressures from NCR and regional manufacturers intensify.
CEO Octavio Marquez should be judged by post-bankruptcy execution, debt reduction pace, service and software revenue mix improvement, R&D investment effectiveness, and the ability to deliver consistent operating margin expansion without sacrificing market share.
The ATM and retail tech industry faces a long-term question about cash usage decline, but ATM upgrades, security mandates, and banking software modernization create replacement cycles. Diebold also benefits from bank branch transformation investments.
At roughly 29x trailing EPS and 0.79x sales, the stock carries a recovery premium. Margin of safety is limited at the current price, but improves if the stock revisits the $60-$70 area while the fundamental turnaround stays on track.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| DBD price | $85.26 | Google Finance quote snapshot | July 12, 2026 |
| Market capitalization | $2.95 billion, verified as $85.26 x 34.63 million shares | financial_rigor.py market cap verification | July 12, 2026 |
| FY2024 revenue | $3.75 billion | Wikipedia / Diebold Nixdorf FY2024 10-K | July 12, 2026 |
| TTM revenue | $3.86 billion (trailing twelve months based on recent quarterly filings) | Yahoo Finance financial summary | July 12, 2026 |
| FY2024 net income | -$15 million | Wikipedia / Diebold Nixdorf FY2024 10-K | July 12, 2026 |
| Q1 FY2026 results | $891.8 million revenue, $5.0 million net income, $0.67 GAAP EPS | Google Finance income statement | July 12, 2026 |
| EPS (TTM) | $2.94 | Google Finance statistics | July 12, 2026 |
| Cash and debt | $358.6 million cash, debt-to-equity ratio of 106.57% | Yahoo Finance balance sheet summary | July 12, 2026 |
| Free cash flow (TTM) | $324.54 million levered FCF | Yahoo Finance cash flow summary | July 12, 2026 |
| Analyst consensus | 2 Buy ratings, consensus price target $100 | Google Finance / Yahoo Finance analyst ratings | July 12, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell DBD stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
